Eiger BioPharmaceuticals to Present at Jefferies 2017 Global Healthcare Conference June 7th
Eiger will also host one-on-one meetings with investors at the
About Eiger
Eiger is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which an effective therapy is urgently needed. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Investors:
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-present-at-jefferies-2017-global-healthcare-conference-june-7th-300465146.html
SOURCE